
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Evaluation of the Anti-Inflammatory Effects of Novel Fatty Acid-Binding Protein 4 Inhibitors in Microglia - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="616CF5BE8095574300F5BE001F43F403.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="springeropen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Neuroimmune Pharmacology">
<meta name="citation_title" content="Evaluation of the Anti-Inflammatory Effects of Novel Fatty Acid-Binding Protein 4 Inhibitors in Microglia">
<meta name="citation_author" content="Yi Ling Low">
<meta name="citation_author_institution" content="Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Ethan Kreutzer">
<meta name="citation_author_institution" content="Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Indu R Chandrashekaran">
<meta name="citation_author_institution" content="Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Luke A Adams">
<meta name="citation_author_institution" content="Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Jason Pun">
<meta name="citation_author_institution" content="Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Bradley C Doak">
<meta name="citation_author_institution" content="Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Yijun Pan">
<meta name="citation_author_institution" content="Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052 Australia">
<meta name="citation_author" content="Jennifer L Short">
<meta name="citation_author_institution" content="Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training, Monash University, Clayton, VIC Australia">
<meta name="citation_author" content="Martin J Scanlon">
<meta name="citation_author_institution" content="Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author" content="Joseph A Nicolazzo">
<meta name="citation_author_institution" content="Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_author_institution" content="Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia">
<meta name="citation_publication_date" content="2025 Apr 16">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="40">
<meta name="citation_doi" content="10.1007/s11481-025-10191-9">
<meta name="citation_pmid" content="40234265">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/pdf/11481_2025_Article_10191.pdf">
<meta name="description" content="Fatty acid-binding protein 4 (FABP4) is a key lipid binding protein expressed in microglia, which has been demonstrated to play a critical role in microglial-mediated neuroinflammation, a component of many neurodegenerative diseases. Compounds able ...">
<meta name="og:title" content="Evaluation of the Anti-Inflammatory Effects of Novel Fatty Acid-Binding Protein 4 Inhibitors in Microglia">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Fatty acid-binding protein 4 (FABP4) is a key lipid binding protein expressed in microglia, which has been demonstrated to play a critical role in microglial-mediated neuroinflammation, a component of many neurodegenerative diseases. Compounds able ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Searchâ€¦
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12000251">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s11481-025-10191-9"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/11481_2025_Article_10191.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000251%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12000251/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12000251/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-springeropen.png" alt="Springer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Springer" title="Link to Springer" shape="default" href="https://doi.org/10.1007/s11481-025-10191-9" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Neuroimmune Pharmacol</button></div>. 2025 Apr 16;20(1):40. doi: <a href="https://doi.org/10.1007/s11481-025-10191-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s11481-025-10191-9</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Neuroimmune%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Neuroimmune%20Pharmacol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Neuroimmune%20Pharmacol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Neuroimmune%20Pharmacol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Evaluation of the Anti-Inflammatory Effects of Novel Fatty Acid-Binding Protein 4 Inhibitors in Microglia</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Low%20YL%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yi Ling Low</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yi Ling Low</span></h3>
<div class="p">
<sup>1</sup>Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Low%20YL%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Ling Low</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kreutzer%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ethan Kreutzer</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ethan Kreutzer</span></h3>
<div class="p">
<sup>1</sup>Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kreutzer%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Ethan Kreutzer</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandrashekaran%20IR%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Indu R Chandrashekaran</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Indu R Chandrashekaran</span></h3>
<div class="p">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>3</sup>ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>4</sup>Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Chandrashekaran%20IR%22%5BAuthor%5D" class="usa-link"><span class="name western">Indu R Chandrashekaran</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adams%20LA%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Luke A Adams</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Luke A Adams</span></h3>
<div class="p">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>4</sup>Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adams%20LA%22%5BAuthor%5D" class="usa-link"><span class="name western">Luke A Adams</span></a>
</div>
</div>
<sup>2,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pun%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jason Pun</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Jason Pun</span></h3>
<div class="p">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>3</sup>ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pun%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jason Pun</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doak%20BC%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Bradley C Doak</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Bradley C Doak</span></h3>
<div class="p">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>4</sup>Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Doak%20BC%22%5BAuthor%5D" class="usa-link"><span class="name western">Bradley C Doak</span></a>
</div>
</div>
<sup>2,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Yijun Pan</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Yijun Pan</span></h3>
<div class="p">
<sup>5</sup>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Pan%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yijun Pan</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Short%20JL%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jennifer L Short</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jennifer L Short</span></h3>
<div class="p">
<sup>6</sup>Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training, Monash University, Clayton, VIC Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Short%20JL%22%5BAuthor%5D" class="usa-link"><span class="name western">Jennifer L Short</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scanlon%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Martin J Scanlon</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Martin J Scanlon</span></h3>
<div class="p">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>3</sup>ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>4</sup>Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Scanlon%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin J Scanlon</span></a>
</div>
</div>
<sup>2,</sup><sup>3,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nicolazzo%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Joseph A Nicolazzo</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Joseph A Nicolazzo</span></h3>
<div class="p">
<sup>1</sup>Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">
<sup>7</sup>Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nicolazzo%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Joseph A Nicolazzo</span></a>
</div>
</div>
<sup>1,</sup><sup>7,</sup><sup>âœ‰</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div id="Aff2">
<sup>2</sup>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div id="Aff3">
<sup>3</sup>ARC Centre for Fragment-Based Design, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div id="Aff4">
<sup>4</sup>Monash Fragment Platform, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div id="Aff5">
<sup>5</sup>Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3052 Australia </div>
<div id="Aff6">
<sup>6</sup>Monash Centre for Advanced mRNA Medicines Manufacturing and Workforce Training, Monash University, Clayton, VIC Australia </div>
<div id="Aff7">
<sup>7</sup>Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052 Australia </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>âœ‰</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 30; Accepted 2025 Mar 20; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Â© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12000251Â Â PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40234265/" class="usa-link">40234265</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Fatty acid-binding protein 4 (FABP4) is a key lipid binding protein expressed in microglia, which has been demonstrated to play a critical role in microglial-mediated neuroinflammation, a component of many neurodegenerative diseases. Compounds able to inhibit the function of FABP4 have shown promise in reducing microglial-mediated neuroinflammation, however, their physicochemical properties would prevent their ability to be easily formulated and traverse the bloodâ€“brain barrier (BBB) in order to access microglial FABP4. To this end, this study assessed the ability of a series of FABP4 inhibitors, with more desirable physicochemical properties, to attenuate microglial inflammation in an in vitro setting. Four inhibitors with varying affinity to FABP4, as measured by isothermal titration calorimetry (MFP-0011462, MFP-0012314, MFP-0012318, and MFP-0012328), were assessed for their ability to induce toxicity and attenuate reactive oxygen species (ROS) generation and tumour necrosis factor-Î± (TNF-Î±) release from lipopolysaccharide (LPS)-activated BV-2 microglia. All FABP4 inhibitors were determined to be soluble in the aqueous buffers at the highest concentration used in the assays (100 ÂµM). Isothermal titration calorimetry demonstrated that the compounds had varying affinities for FABP4 (K<sub>D</sub> values of 316Â nM toâ€‰&gt;â€‰100 ÂµM). The ability of FABP4 inhibitors to reduce LPS-mediated ROS production aligned with their K<sub>D</sub> for FABP4, with the most effective inhibitor (MFP-0012328) also able to reduce TNF-Î± production (by RT-qPCR) and TNF-Î± release from LPS-activated BV-2 cells by 17% and 25%, respectively. These studies have demonstrated that a series of FABP4 inhibitors with more appropriate physicochemical properties for BBB penetration are able to reduce microglial-mediated inflammation, which may be of benefit in diseasesÂ where overactivation of microglia leads to neurodegeneration.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1007/s11481-025-10191-9.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Fatty acid-binding protein 4, Microglia, Reactive oxygen species, Tumour necrosis factor alpha, Neuroinflammation</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par2">Neuroinflammation is defined as an inflammatory process of the central nervous system (CNS), and it is a common pathology associated with various neurodegenerative diseases, such as Alzheimerâ€™s disease (AD), Parkinsonâ€™s disease (PD), and motor neuron disease (MND) (Gao et al. <a href="#CR9" class="usa-link" aria-describedby="CR9">2023</a>). Neuroinflammation is characterised by the excessive release of proinflammatory cytokines from microglia, the main immune cell of the CNS. A continued elevation in the concentrations of proinflammatory molecules such as interleukin-1Î² (IL-1Î²), tumour necrosis factor-Î± (TNF-Î±), reactive oxygen species (ROS), and nitric oxide (NO) can lead to severe reductions in neuronal number and function (Araujo Boleti et al. <a href="#CR3" class="usa-link" aria-describedby="CR3">2020</a>). Given that microglia are heavily involved in the neuroinflammatory process, there is growing interest in targeting microglial activation as a therapeutic approach to reduce neurodegenerative processes associated with diseases such as AD, PD, and MND (Subhramanyam et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2019</a>).</p>
<p id="Par3">Recent studies have reported on the involvement of a fatty acid-binding protein (FABP) isoform in the activation process in both macrophages and microglia (Hui et al. <a href="#CR13" class="usa-link" aria-describedby="CR13">2010</a>; Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). FABPs are a family of non-catalytic chaperones that are capable of binding to a variety of fatty acids and other hydrophobic ligands and they regulate a number of biological processes in cells with a high fatty acid turnover (Zimmerman et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2001</a>). One FABP isoform, adipose FABP, otherwise known as FABP4, is expressed largely in adipocytes and plays an important role in various metabolic and inflammatory pathways. FABP4 promotes lipolysis and therefore contributes to the accumulation of lipids and the development of harmful secondary conditions such as type 2 diabetes and atherosclerosis (Furuhashi and Hotamisligil <a href="#CR7" class="usa-link" aria-describedby="CR7">2008</a>; Furuhashi et al. <a href="#CR8" class="usa-link" aria-describedby="CR8">2007</a>). In addition to its roles in adipocytes, FABP4 is expressed in peripheral macrophages, where it is known to promote a pro-inflammatory response (Furuhashi et al. <a href="#CR8" class="usa-link" aria-describedby="CR8">2007</a>). In peripheral inflammatory disorders, such as obesity, cardiovascular disease, atherosclerosis and rheumatoid arthritis, the expression of FABP4 in macrophages is increased, and pharmacological inhibition through FABP4 inhibitors, such as BMS309403, reduces negative outcomes in animal models of these peripheral diseases (Furuhashi et al. <a href="#CR8" class="usa-link" aria-describedby="CR8">2007</a>; Guo et al. <a href="#CR10" class="usa-link" aria-describedby="CR10">2022</a>; Lan et al. <a href="#CR16" class="usa-link" aria-describedby="CR16">2011</a>). While most FABP4 research has focused on adipocytes and peripheral macrophages, we have more recently confirmed that FABP4 is expressed in BV-2 cells, an immortalised mouse microglial cell line, at both the mRNA and protein level and in primary mouse microglia at the mRNA level (Low et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2021</a>). As in the periphery, FABP4 plays a significant role in mediating the release of inflammatory mediators from microglia, which has been suggested to occur through the role of FABP4 in inhibiting the anti-oxidative mediator uncoupling protein 2 (Duffy et al. <a href="#CR5" class="usa-link" aria-describedby="CR5">2017</a>). Brain cortical expression of FABP4 has been shown to be increased in a HIV-induced model of neuroinflammation, which was mediated through nuclear factor kappa B (NF-ÎºB), and in this model, genetic inhibition of microglial FABP4 attenuated neuroinflammation (Zhou et al. <a href="#CR33" class="usa-link" aria-describedby="CR33">2022</a>). Similarly, it was demonstrated that genetic and chemical inhibition of FABP4 (through BMS309403) significantly reduced the lipopolysaccharide (LPS)-induced release of proinflammatory molecules from BV-2 cells and in primary mouse microglia (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). These studies suggest that inhibiting the function of FABP4 may be a novel therapeutic approach to reduce microglial-mediated neuroinflammation.</p>
<p id="Par4">Studies have reported on various FABP4 inhibitors being synthesised for the treatment of diabetes and atherosclerosis, including derivatives of niacin, quinoxaline, aryl-quinoline, bicyclic pyridine, urea, aromatic compounds, and other heterocyclic compounds (Floresta et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2017</a>). These inhibitors have been widely studied for their protein-drug interactions and selectivity towards FABP4 as compared to other FABP isoforms. Currently, BMS309403, a potent and highly selective FABP4 inhibitor, is the most commonly studied FABP4 inhibitor in both in vitro and in vivo models, and is indeed the FABP4 inhibitor previously shown to reduce LPS-mediated neuroinflammation in microglia (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). BMS309403 has an inhibitory constant (K<sub>i</sub>) for FABP4 of less than 2 nM (Floresta et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2017</a>), and it has been shown to be very selective for FABP4 over other FABP isoforms (Sulsky et al. <a href="#CR31" class="usa-link" aria-describedby="CR31">2007</a>). However, despite being highly selective for FABP4, BMS309403 has a very high LogP of 7.2 and a molecular weight of 474.5 Da (PubChem <a href="#CR28" class="usa-link" aria-describedby="CR28">2021</a>), properties which may reduce the ability of this compound to be formulated as an oral product and to alsoÂ permeate the bloodâ€“brain barrier (BBB). Exhibiting appropriate physicochemical properties to cross the BBB would be critical for any potential therapeutic to access the microglia following peripheral administration, which include a log D in the range of 1â€“3, a molecular weightâ€‰&lt;â€‰450 Da and a topological polar surface area (tPSA) ofâ€‰&lt;â€‰60â€“90Ã…<sup>2</sup> (Nicolazzo et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2006</a>). While BMS309403 has an appropriate tPSA for BBB penetration (i.e. 64.4 Ã…<sup>2</sup>), its large molecular weight and high lipophilicity may prevent its ability to traverse the BBB by passive diffusion. Other FABP4 inhibitors have been designed, such as HTS01037, which has high affinity and selectivity for FABP4 and therefore, attenuation of inflammatory mediators from macrophages (Hertzel et al. <a href="#CR12" class="usa-link" aria-describedby="CR12">2009</a>), however, the polarity of this compound (with a tPSA of 149 Ã…<sup>2</sup>) (PubChem <a href="#CR28" class="usa-link" aria-describedby="CR28">2021</a>) would likely limit BBB penetration.</p>
<p id="Par5">There is therefore a need to develop compounds that are not only able to bind potently and selectively to FABP4, but also exhibit physicochemical properties for optimum BBB penetration so as to more efficiently alleviate microglial-mediated neuroinflammation. Furthermore, these FABP4 inhibitors should exhibit appropriate solubility so that they can be formulated for in vivo application. The overall aim of this study, therefore, was to screen novel FABP4 inhibitors with more appropriate physicochemical properties for BBB penetration, and to evaluate the effectiveness of these compounds in reducing proinflammatory molecule release from LPS-activated microglia. This study assessed the aqueous solubility of four novel FABP4 inhibitors from the same chemical series (i.e. all with a sulfonamide scaffold) as compared to BMS309403, their tolerance in BV-2 cells and their ability to reduce the release of proinflammatory molecules from LPS-activated BV-2 cells, so as to identify a novel FABP4 inhibitor for further preclinical characterisation in neuroinflammation.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Materials</h3>
<p id="Par6">Dr. Linda J. Van Eldik generously provided the BV-2 cells, which originated from the laboratory of Dr. Elisabetta Blasi (Lexington, KY) (Blasi et al. <a href="#CR1" class="usa-link" aria-describedby="CR1">1990</a>). Dulbeccoâ€™s sterile phosphate buffer saline (PBS), fetal bovine serum (FBS), Hankâ€™s Balanced Salt Solution (HBSS), Pierce BCA Protein Assay kit, and mouse TNF-Î± uncoated ELISA kit were all purchased from Thermo Fisher Scientific (Grand Island, NY). Dulbeccoâ€™s Modified Eagleâ€™s Medium F-12 Ham (DMEM/F-12), trypsin, trypan blue, Î²-mercaptoethanol, dimethyl sulfoxide (DMSO), d<sub>6</sub>-DMSO, bovine serum albumin (BSA), thiazolyl blue tetrazolium bromide (MTT), penicillin/streptomycin, LPS from Escherichia coli O111:B4, sodium phosphate (Na<sub>2</sub>HPO<sub>4</sub>), sodium chloride (NaCl), 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS), and 2â€²,7â€²-dichlorofluorescin diacetate (DCF-DA) were all purchased from Sigma-Aldrich (St Louis, MO). iTaq Universal Probes One-Step kit (containing 2â€‰Ã—â€‰probes RT-PCR reaction mix, iScript reverse transcriptase, and nuclease-free water) was purchased from BioRad (Hercules, CA). QIAshredder columns, RNeasy Mini Plus kit, HiPerfect transfection reagent, FlexiTube FABP4 siRNA (SI02695322), and AllStar Negative Control siRNA were purchased from Qiagen (Hilden, Germany). Taqman gene assays for TNF-Î±, Î²-actin, and GAPDH were purchased from Applied Biosystems (Foster City, CA). BMS309403 was purchased from Cayman Chemicals (Ann Arbor, MI). MFP-0012328, MFP-0012314, and MFP-0012318 were purchased from Enamine (Kyiv, Ukraine), while MFP-0011462 was purchased from ChemBridge (San Diego, CA).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Selection of Compounds Targeting FABP4 and Assessment of their Affinity to FABP4</h3>
<p id="Par7">A prior fragment screen identified a series of bi-aryl sulfonamides that bound to FABP4. Analogues of this chemical sulfonamide scaffold were then purchased, which led to the identification of the compounds used in this study (MFP-0011462, MFP-0012314, MFP-0012318, and MFP-0012328). Their predicted LogP and tPSA values were calculated in Vortex v2020.1.117658-s (Dotmatics, Boston, MA). The binding affinity of these four compounds was characterised by isothermal titration calorimetry (ITC). ITC was carried out using an iTC200 microcalorimeter (MicroCal, United Kingdom) with a coin shaped sample cell (201.4 Î¼L) with stirring at 1000 rpm at 25Â°C. Titrations were performed in an ITC buffer (50 mM sodium phosphate, 50 mM NaCl, pH 7.4 with 2% DMSO). Compounds were diluted from concentrated stocks in ITC buffer and loaded into the titration syringe at a concentration of 1 mM, with a final DMSO concentration of 2% (v/v). Recombinantly-expressed human FABP4 was prepared as described previously (Lee et al. <a href="#CR19" class="usa-link" aria-describedby="CR19">2015a</a>) in an identical buffer at a protein concentration of 80 Î¼M and placed in the sample cell. A thermal equilibration step at 25Â°C was followed by an initial 180 s delay step and subsequently an initial 0.2 Î¼L injection. 16 serial injections of the 1 mM compound solution (2 Î¼L each) were made at intervals of 220 s with continuous stirring of the solution in the sample cell. The iTC200 control software was used to operate and acquire raw data as power (microcalories/sec) vs time (min). The data were processed using the Origin 7.0 software (MicroCal) and the binding affinity (K<sub>D</sub>) was calculated by fitting the data to a one-site binding model.</p></section><section id="Sec5"><h3 class="pmc_sec_title">1D <sup>1</sup>H NMR to Assess Aqueous Solubility</h3>
<p id="Par8">1D <sup>1</sup>H NMR was employed to determine the solubility limits of the four MFP compounds and BMS309403 in phosphate buffer. This method has been commonly used to determine compound solubility in the drug discovery setting (Devine et al. <a href="#CR4" class="usa-link" aria-describedby="CR4">2014</a>; Lee et al. <a href="#CR20" class="usa-link" aria-describedby="CR20">2015b</a>; Lin et al. <a href="#CR21" class="usa-link" aria-describedby="CR21">2009</a>). A 100 mM of stock solution of each compound was first prepared in d<sub>6</sub>-DMSO. These stock solutions were then added into phosphate buffer (50 mM sodium phosphate, 25 mM NaCl, 100 ÂµM of DSS, pH 7.4 in D<sub>2</sub>O) to achieve a final d<sub>6</sub>-DMSO concentration of 0.1% (v/v) which is equivalent to the DMSO concentration present in BV-2 cell culture experiments. All samples were inspected to note whether visible precipitates were formed. <sup>1</sup>H NMR spectra for all of the samples were acquired using Bruker Avance III 600 MHz spectrometer at 25 Â°C. Experimental data were acquired using a relaxation delay of 5 s with 128 scans, and water suppression using an excitation sculpting pulse scheme. Mestrelab Research 13.0 software was used to integrate the proton resonances of the compounds. A well-resolved peak (i.e. no overlaps with any other peaks) in the spectrum of each compound was chosen for integration, relative to the DSS peak (at 0 ppm). The integrated value was then plotted against the compound concentration to determine whether the aqueous solubility was linear over the concentration range tested. In addition, the chemical shifts of the resonances in the 1D <sup>1</sup>H NMR spectra were monitored. Compounds that showed a linear increase in peak intensity with concentration and no measurable change in chemical shift were considered to be soluble and free from aggregation over the tested concentration range.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Culturing and Treatment of BV-2 Cells</h3>
<p id="Par9">BV-2 cells were cultured in DMEM/F-12 media supplemented with 10% (v/v) FBS and 1% (v/v) penicillin/streptomycin, and kept at 37 Â°C in a humidified incubator (95% O<sub>2</sub>, 5% CO<sub>2</sub>) for all studies. Cells with 80% confluency were used for experiments. At 24 h post-seeding, BV-2 cells were treated with either of the MFP compounds (at concentrations detailed below) or vehicle (0.1% (v/v) DMSO) and 1 Âµg/mL LPS for a period of 24 h. In some experiments (detailed in Results), BV-2 cells were exposed to MFP compounds for 2 h before a 24 h exposure to LPS and MFP compounds, and in some studies, in the presence of FABP4 siRNA using a 24 h treatment thatÂ we have previously employed (Low et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2021</a>). In brief, BV-2 cells were washed once 4 h post-seeding with blank DMEM/F-12 media. siRNA complexes (containing FABP4 siRNA, target sequence 5â€™-CTGGATGGAAATTTGCATCAA-3â€™ or AllStar Negative Control siRNA, target sequence proprietary) were added dropwise onto the cells. siRNA complexes were prepared by mixing siRNA and HiPerfect transfection reagent together in FBS-free DMEM/F12 media and incubating for 15 min to allow the siRNA complexes to form. The cells were incubated with the siRNA complex for 5 min, after which, DMEM/F12 media containing FBS was added into each well to dilute the siRNA complexes to 5 nM.</p></section><section id="Sec7"><h3 class="pmc_sec_title">MTT Assay to Assess BV-2 cell Viability Following MFP Compound Treatments</h3>
<p id="Par10">To determine the most appropriate and tolerable concentration of MFP compounds in BV-2 cells, an MTT assay was performed. Following treatment with increasing concentrations of MFP compounds for 24 h, BV-2 cells were rinsed once with PBS prior to being incubated with 0.45 mg/mL MTT reagent for 4 h in a 37 Â°C, 5% CO<sub>2</sub> incubator. After that, the MTT reagent was removed and 150 ÂµL of DMSO was added into all wells for 30 min. The plate was then immediately read on a Perkin-Elmer Enspire fluorescence plate reader (Boston, MA) at 540 nm. Background subtraction was performed before the percentage cell viability was calculated and expressed as a ratio of mean absorbance of MFP-treated cells over mean absorbance of vehicle-treated cells.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Measurement of Intracellular ROS</h3>
<p id="Par11">Intracellular ROS in BV-2 cells, following treatment with MFP compounds and LPS, was detected using the widely-used membrane permeable probe, DCF-DA. Post treatment, BV-2 cells were rinsed once with warm HBSS prior to being incubated with 40 ÂµM of DCF-DA for 30 min at 37Â°C, 5% CO<sub>2</sub>. The wells were then rinsed again with HBSS before being read on a Perkin-Elmer Enspire plate reader (Î»<sub>ex</sub>: 488 nm, Î»<sub>em</sub>: 535 nm) as we have reported previously (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>).</p></section><section id="Sec9"><h3 class="pmc_sec_title">Measurement of Extracellular Nitrite</h3>
<p id="Par12">For measurement of extracellular nitrite concentrations, the Griess assay was performed as per the manufacturerâ€™s protocol (Molecular Probes, Eugene, OR) with minor changes. Griess reagent components were separated and added sequentially, with sulfanilic acid added to samples first followed by a 15 min incubation and then <em>N-</em>(1-naphthyl)ethylenediamine dihydrochloride was added followed by a further 15 min incubation. Deionised water was not included given standards were prepared in media for comparison with media samples. The absorbance of the media samples was measured on a Perkin-Elmer Enspire plate reader at 548 nm, with nitrite concentrations in media samples obtained by back calculating sample absorbance values back to a standard curve prepared through serial dilution of NaNO<sub>2</sub> prepared in media.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Quantification of TNF-Î± Concentration Using Enzyme-Linked immunosorbent Assay (ELISA)</h3>
<p id="Par13">ELISA was performed as per manufacturerâ€™s protocol to measure the concentration of TNF-Î± in the supernatant in which BV-2 cells were treated. In short, 100 ÂµL of supernatant, alongside 100 ÂµL of TNF-Î± standards, were aliquoted into pre-coated ELISA plates. Following a 2 h incubation, the wells were washed with wash buffer (0.05% (w/v) Tween-20 in PBS) four times before 100 ÂµL of detection antibody was added for 1 h. After washing the wells four times, 100 ÂµL of streptavidin-HRP was added for 30 min. The wells were again washed six times before 100 ÂµL of TMB substrate was added for 15 min. 100 ÂµL of Stop solution was added into each well before the plate was immediately read on a Perkin-Elmer Enspire fluorescence plate reader at 450 nm (excitation) and 570 nm (absorbance). Absorbance values at 570 nm were subtracted from 450 nm to account for background. TNF-Î± concentration was normalised to total protein count (mg), as quantified by a BCA assay, and reported as pg/mg protein.</p></section><section id="Sec11"><h3 class="pmc_sec_title">RT-qPCR for TNF-Î± mRNA Expression</h3>
<p id="Par14">RT-qPCR was performed to determine the amount of TNF-Î± mRNA following the required cell treatments, as previously described (Low et al. <a href="#CR23" class="usa-link" aria-describedby="CR23">2020</a>). In brief, BV-2 cells were washed twice with ice-cold PBS before RNA isolation was performed using the RNeasy Plus Mini kit as per the manufacturerâ€™s protocol. The concentration and purity of the isolated RNA was assessed using a Thermo Fisher Nanodrop 1000 spectrophotometer (Rockford, IL). RT-qPCR reactions were performed using a BioRad C1000 thermocycler in a CFX96 system (Hercules, CA). In accordance with the manufacturerâ€™s instructions, each PCR reaction mix contained 12.5 Î¼L of 2â€‰Ã—â€‰probes RT-PCR reaction mix, 0.5 Î¼L of iScript reverse transcriptase, 6.3 Î¼L of nuclease-free water, 0.695 Î¼L of Taqman primer, and 100 ng of isolated RNA. Thermocycling was performed at 50 Â°C for 10 min, and then 95 Â°C for 5 min, followed by 45 cycles of 95 Â°C for 15 s and 60 Â°C for 30 s. The threshold cycles (C<sub>t</sub>) were automatically calculated using the CFX manager software. The fold-change method (2<sup>âˆ’Î”Î”C</sup><sub>t</sub>), as detailed in the equation below, was used to determine the mRNA levels of TNF-Î± relative to Î²-actin and GAPDH (housekeeping genes), and fold changes were calculated as a ratio to vehicle-control cells.</p>
<table class="disp-formula p" id="Equa"><tr><td class="formula"><math id="d33e493" display="block"><mrow><mi mathvariant="normal">Î”</mi><mi>C</mi><mi>t</mi><mo>=</mo><msub><mi>C</mi><mrow><mi>t</mi><mo stretchy="false">(</mo><mi>T</mi><mi>N</mi><mi>F</mi><mo>-</mo><mi>Î±</mi><mo stretchy="false">)</mo></mrow></msub><mo>-</mo><msub><mrow><mo stretchy="false">(</mo><mi>C</mi></mrow><mrow><mi>t</mi><mfenced close=")" open="("><mi>Î²</mi><mo>-</mo><mi>a</mi><mi>c</mi><mi>t</mi><mi>i</mi><mi>n</mi></mfenced></mrow></msub><mo>+</mo><msub><mi>C</mi><mrow><mi>t</mi><mfenced close=")" open="("><mi>G</mi><mi>A</mi><mi>P</mi><mi>D</mi><mi>H</mi></mfenced></mrow></msub><mrow><mo stretchy="false">)</mo><mo stretchy="false">/</mo><mn>2</mn></mrow></mrow></math></td></tr></table>
<table class="disp-formula p" id="Equb"><tr><td class="formula"><math id="d33e552" display="block"><mrow><mi mathvariant="normal">Î”</mi><mi mathvariant="normal">Î”</mi><mi>C</mi><mi>t</mi><mo>=</mo><msub><mi>C</mi><mrow><mi>t</mi><mo stretchy="false">(</mo><mi>t</mi><mi>r</mi><mi>e</mi><mi>a</mi><mi>t</mi><mi>e</mi><mi>d</mi><mo stretchy="false">)</mo></mrow></msub><mo>-</mo><msub><mi>C</mi><mrow><mi>t</mi><mfenced close=")" open="("><mi>c</mi><mi>o</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>o</mi><mi>l</mi></mfenced></mrow></msub></mrow></math></td></tr></table>
<table class="disp-formula p" id="Equc"><tr><td class="formula"><math id="d33e595" display="block"><mrow><msup><mrow><mn>2</mn></mrow><mrow><mo>-</mo><mi mathvariant="normal">Î”</mi><mi mathvariant="normal">Î”</mi><mi>C</mi><mi>t</mi></mrow></msup><mo>=</mo><mi>f</mi><mi>o</mi><mi>l</mi><mi>d</mi><mspace width="0.277778em"></mspace><mi>c</mi><mi>h</mi><mi>a</mi><mi>n</mi><mi>g</mi><mi>e</mi><mspace width="0.277778em"></mspace><mi>o</mi><mi>f</mi><mspace width="0.277778em"></mspace><mi>T</mi><mi>N</mi><mi>F</mi><mo>-</mo><mi>Î±</mi><mspace width="0.277778em"></mspace><mi>n</mi><mi>o</mi><mi>r</mi><mi>m</mi><mi>a</mi><mi>l</mi><mi>i</mi><mi>s</mi><mi>e</mi><mi>d</mi><mspace width="0.277778em"></mspace><mi>t</mi><mi>o</mi><mspace width="0.277778em"></mspace><mi>Î²</mi><mo>-</mo><mi>a</mi><mi>c</mi><mi>t</mi><mi>i</mi><mi>n</mi><mspace width="0.277778em"></mspace><mi>a</mi><mi>n</mi><mi>d</mi><mspace width="0.277778em"></mspace><mi>G</mi><mi>A</mi><mi>P</mi><mi>D</mi><mi>H</mi></mrow></math></td></tr></table></section><section id="Sec12"><h3 class="pmc_sec_title">Data and Statistical Analyses</h3>
<p id="Par15">Data analyses were performed using Graphpad Prism 8 (GraphPad, La Jolla, CA). All data were expressed as meanâ€‰Â±â€‰SEM, where all replicates performed were biological replicates. When comparing between two groups, a Studentâ€™s unpaired t-test was performed. When more than two groups were compared, an analysis of variance (ANOVA), followed by an appropriate post-hoc test was performed. Values of pâ€‰&lt;â€‰0.05 were considered statistically significant.</p></section></section><section id="Sec13"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec14"><h3 class="pmc_sec_title">Predicted Physicochemical Properties of MFP Compounds and BMS309403</h3>
<p id="Par16">The physicochemical properties of the compounds of interest (i.e. the four MFP compounds) and BMS309403 were predicted to assist in understanding their aqueous solubility and potential to permeate the BBB. These properties including molecular weight, logP and tPSA are provided in TableÂ <a href="#Tab1" class="usa-link">1</a>, alongside the K<sub>D</sub> values against FABP4, determined by ITC (Figure <a href="#MOESM1" class="usa-link">S1</a>).</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">TableÂ 1.</h4>
<div class="caption p"><p>Structures, molecular weight, predicted LogP, predicted tPSA and K<sub>D</sub> against FABP4 for each of the MFP compounds and BMS309403</p></div>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Tab1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/4bb71259d351/11481_2025_10191_Tab1_HTML.jpg" loading="lazy" id="MO1" height="709" width="779" alt="graphic file with name 11481_2025_10191_Tab1_HTML.jpg"></a></p>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p20">
<p><sup>a</sup>Vortex v2020.1.117658-s</p>
<p><sup>b</sup>This K<sub>i</sub> was obtained from a previously-published study (Floresta et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2017</a>)</p>
</div></div></section><p id="Par17">Since both LogP and tPSA can affect how compounds behave in an aqueous buffer and therefore affect their binding affinity towards FABP4, the relationships between binding affinity, LogP, and tPSA were investigated. From Fig.Â <a href="#Fig1" class="usa-link">1</a>A, a negative relationship for binding affinity and LogP was observed, where compounds with a higher binding affinity towards FABP4 have a higher LogP value. In contrast, Fig.Â <a href="#Fig1" class="usa-link">1</a>B illustrated that there is a positive relationship for binding affinity and tPSA, where compounds with higher binding affinities have lower tPSA values.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig.Â 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/39ae000cba0a/11481_2025_10191_Fig1_HTML.jpg" loading="lazy" id="MO2" height="1019" width="646" alt="Fig.Â 1"></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The relationship between K<sub>D</sub> towards FABP4 and (<strong>A</strong>) LogP and (<strong>B</strong>) tPSA of FABP4 inhibitors. A negative relationship for K<sub>D</sub> and LogP was observed, while K<sub>D</sub> and tPSA demonstrated a positive relationship</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">All FABP4 Inhibitors were Soluble in Phosphate Buffer</h3>
<p id="Par18">The aqueous solubility of each of the novel FABP4 inhibitors and BMS309403 was assessed using <sup>1</sup>H NMR. As shown in Figure S2, the signal intensity for all MFP compounds increased proportionally to concentration over the concentration range assessed (Fig.Â <a href="#Fig2" class="usa-link">2</a>), indicating that the compounds were soluble in the phosphate buffer up to 100 ÂµM. There was also no change in chemical shifts with increasing concentrations. Interestingly, the same observation was made for BMS309403, despite its very high LogP value.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig.Â 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/b0bc3838cede/11481_2025_10191_Fig2_HTML.jpg" loading="lazy" id="MO3" height="371" width="677" alt="Fig.Â 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Relative peak intensities of MFP-0012318, MFP-0011462, MFP-0012314, MFP-0012328, and BMS309403 (to DSS) at different concentrations in phosphate buffer, ranging from 3.125â€“100Â ÂµM using <sup>1</sup>H NMR. RepresentativeÂ <sup>1</sup>H NMR spectra of each compound at increasing concentration in phosphate buffer are shown in Figure S2</p></figcaption></figure><p id="Par19">Since all MFP compounds showed acceptable solubility in aqueous buffer, these compounds were then screened using in vitro assays to determine any potential toxicity and if their difference in binding affinity to FABP4 correlated to how well they were able to reduce the release of proinflammatory molecules from LPS-activated BV-2 cells.</p></section><section id="Sec16"><h3 class="pmc_sec_title">MFP Compounds were well Tolerated at Moderate Concentrations in BV-2 Cells</h3>
<p id="Par20">Before assessing the ability of these MFP compounds to reduce proinflammatory mediator release from LPS-activated BV-2 cells, an MTT assay was performed to identify their tolerable concentrations in these cells. As shown in Fig.Â <a href="#Fig3" class="usa-link">3</a>, all MFP compounds were well tolerated up to a concentration ofÂ 50 ÂµM. Higher concentrations of all compounds resulted in a 17.0â€“27.3% reduction in cell viability. Therefore, 50 ÂµM of each compound was used for subsequent studies, which is consistent with the concentration of BMS309403 previously shown to reduce LPS-mediated release of inflammatory mediators from BV-2 cells (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig.Â 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/2a9c149879c7/11481_2025_10191_Fig3_HTML.jpg" loading="lazy" id="MO4" height="441" width="677" alt="Fig.Â 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>BV-2 cell viability following treatment with increasing concentrationsÂ of MFP compounds. Relative to vehicle control, no significant differences in BV-2 cell viability were observed following treatment with 2â€“50Â ÂµM of MFP-0012328, MFP-0011462, MFP-0012314, and MFP-0012318, while treatment with 75Â ÂµM and 100Â ÂµM of MFP-0012328 and 100Â ÂµM of MFP-0011462, MFP-0012314, and MFP-0012318 resulted in a 0.17â€“0.27-fold reduction in cell viability. 10% DMSO served as a positive control. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰6 biological replicates), where *pâ€‰&lt;â€‰0.05, **pâ€‰&lt;â€‰0.01, ***pâ€‰&lt;â€‰0.001, and ****pâ€‰&lt;â€‰0.0001, as assessed using a one-way ANOVA, followed by a post-hoc Dunnettâ€™s test</p></figcaption></figure></section><section id="Sec17"><h3 class="pmc_sec_title">MFP Compounds Reduced LPS-Mediated ROS Production in BV-2 Cells in a Concentration-Dependent Manner</h3>
<p id="Par21">Concentrations of 50 ÂµM of MFP-0012328, MFP-0011462, MFP-0012314, and MFP-0012318 were all found to significantly reduce ROS production relative to LPS-only treated cells, as summarised in TableÂ <a href="#Tab2" class="usa-link">2</a>. This result was unexpected as it suggested that binding affinity of the inhibitor towards FABP4 plays no role in determining inhibitor efficacy (given that MFP-0012318 exhibits a K<sub>D</sub> for FABP4 exceeding 100 ÂµM). To ensure that the concentration of MFP compounds used was not saturating FABP4 in these studies, a lower concentration of MFP compounds was used. Interestingly, at 10 ÂµM, the reduction in intracellular ROS production was associated with the binding affinity of the compound towards FABP4, as MFP-0012328 (K<sub>D</sub>: 0.316 ÂµM) was able to reduce ROS production the most, while MFP-0012318 had no effect on ROS production. This indicated that binding affinity to FABP4 played a role inÂ the ability to attenuate LPS-mediated ROS production. Given that MFP-0012328 reduced ROS production the most, this compound was further investigated in subsequent studies.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">TableÂ 2.</h4>
<div class="caption p"><p>Intracellular ROS production in BV-2 cells following pre-treatment with 50Â ÂµM or 10Â ÂµM of MFP compounds for 2Â h, followed by co-treatment with MFP compounds and 1Â Âµg/mL LPS for 24Â h. **pâ€‰&lt;â€‰0.01, ***pâ€‰&lt;â€‰0.001, and ****pâ€‰&lt;â€‰0.0001 compared to LPS-only treated BV-2 cells, nâ€‰=â€‰6 biological replicates</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Compound</th>
<th align="left" colspan="2" rowspan="1">% reduction in intracellular ROS production (meanâ€‰Â±â€‰SEM)</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">50 ÂµM</th>
<th align="left" colspan="1" rowspan="1">10 ÂµM</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">MFP-0012328</td>
<td align="center" colspan="1" rowspan="1">23â€‰Â±â€‰0.10 (**pâ€‰&lt;â€‰0.01)</td>
<td align="center" colspan="1" rowspan="1">51â€‰Â±â€‰0.07 (****pâ€‰&lt;â€‰0.0001)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MFP-0011462</td>
<td align="center" colspan="1" rowspan="1">46â€‰Â±â€‰0.08 (***pâ€‰&lt;â€‰0.001)</td>
<td align="center" colspan="1" rowspan="1">49â€‰Â±â€‰0.04 (****pâ€‰&lt;â€‰0.0001)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MFP-0012314</td>
<td align="center" colspan="1" rowspan="1">42â€‰Â±â€‰0.07 (***pâ€‰&lt;â€‰0.001)</td>
<td align="center" colspan="1" rowspan="1">40â€‰Â±â€‰0.09 (**pâ€‰&lt;â€‰0.01)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MFP-0012318</td>
<td align="center" colspan="1" rowspan="1">54â€‰Â±â€‰0.09 (****pâ€‰&lt;â€‰0.0001)</td>
<td align="center" colspan="1" rowspan="1">0.5â€‰Â±â€‰0.10 (ns)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec18"><h3 class="pmc_sec_title">MFP Compounds Reduced LPS-Mediated Nitrite Release from BV-2 Cells</h3>
<p id="Par22">As a secondary readout, the ability of the MFP compounds to attenuate LPS-mediated BV-2 release of nitrite was examined. Given that MFP-0012318 did not reduce ROS production at a concentration of 10 ÂµM, this compound was not evaluated for its nitrite-attenuating effects. As expected, LPS significantly increased the release of nitrite from BV-2 cells (Fig.Â <a href="#Fig4" class="usa-link">4</a>). Interestingly, all compounds attenuated the LPS-mediated release of nitrite from BV-2 cells when used at a concentration of 50 ÂµM ranging from 12.2% for MFP-0011462 to 51.3% for MFP-0012328 (Fig.Â <a href="#Fig4" class="usa-link">4</a>B), however, these compounds elicited no effect on LPS-mediated nitrite release when used at a concentration of 10 ÂµM, suggesting that ROS production is more sensitive to these MFP compounds than is nitrite release from the BV-2 cells.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig.Â 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/2f92969fbaac/11481_2025_10191_Fig4_HTML.jpg" loading="lazy" id="MO5" height="283" width="677" alt="Fig.Â 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Nitrite release from BV-2 cells following treatment with MFP-0011462, MFP-0012314 or MFP-0012328 at (<strong>a</strong>) 10Â ÂµM or (<strong>b</strong>) 50Â ÂµM in the presence and absence of 1Â Âµg/mL LPS for 24Â h. LPS was able to significantly increase nitrite release from BV-2 cells after 24Â h. Treatment with all MFP compounds significantly reduced LPS-mediated nitrite release from BV-2 cells at 50Â ÂµM, but not at 10Â ÂµM. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰4 biological replicates), where *pâ€‰&lt;â€‰0.05 and ****pâ€‰&lt;â€‰0.0001, as assessed using a two-way ANOVA, followed by a post-hoc Tukeyâ€™s test</p></figcaption></figure></section><section id="Sec19"><h3 class="pmc_sec_title">The ROS-Attenuating Effects of MFP-0012328 were FABP4 Mediated</h3>
<p id="Par23">To ensure that the effect of MFP-0012328, as the most effective ROS-attenuating compound, was mediated through inhibition of FABP4, and not on other targets, the effect of MFP-0012328 was assessed in the presence and absence of FABP4 siRNA. From Fig.Â <a href="#Fig5" class="usa-link">5</a>, it can be observed that MFP-0012328 was not able to reduce ROS levels any further in FABP4 siRNA treated cells relative to BV-2 cells with FABP4 present. This indicated that the ROS-reducing effects of MFP-0012328 were most likely mediated through inhibition of FABP4.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig.Â 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/ab36b1d5b8c3/11481_2025_10191_Fig5_HTML.jpg" loading="lazy" id="MO6" height="446" width="645" alt="Fig.Â 5"></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>ROS production in BV-2 cells following treatment with either 5Â nM of FABP4 siRNA, 10Â ÂµM MFP-0012328, or both, in the presence of 1Â Âµg/mL LPS for 24Â h. LPS was able to significantly increase ROS production in BV-2 cells after 24Â h. Treatment with either FABP4 siRNA, MFP-0012328, or with both, significantly reduced ROS production by 36.6â€“61.2%, as compared to the LPS-treated BV-2 cells. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰6 biological replicates), where *pâ€‰&lt;â€‰0.05 when compared to LPS-only treatment and #pâ€‰&lt;â€‰0.05 when compared to control treatment, as assessed using a one-way ANOVA, followed by a post-hoc Tukeyâ€™s test</p></figcaption></figure></section><section id="Sec20"><h3 class="pmc_sec_title">MFP-0012328 Reduced TNF-Î± mRNA Expression and Protein Concentration in LPS-Activated BV-2 Cells</h3>
<p id="Par24">We further investigated if MFP-0012328 was also able to reduce the concentration of the common proinflammatory molecule, TNF-Î±, in addition to its ROS and nitrite attenuating effects. As shown in Fig.Â <a href="#Fig6" class="usa-link">6</a>A, pre-treating BV-2 cells with MFP-0012328 led to a significant (24.8%) reduction in extracellular concentration of TNF-Î± relative to LPS-only treated cells. The reduction in extracellular TNF-Î± concentration correlated to a reduction in TNF-Î± mRNA production (Fig.Â <a href="#Fig6" class="usa-link">6</a>B), confirming that the effect of MFP-0012328 on TNF-Î± was transcriptional in nature. These results suggested that MFP-0012328 is a useful FABP4 inhibitor in reducing three inflammatory mediators from activated microglia.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig.Â 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/5bda53b606e8/11481_2025_10191_Fig6_HTML.jpg" loading="lazy" id="MO7" height="552" width="677" alt="Fig.Â 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) The amount of TNF-Î± protein released by BV-2 cells following treatment with 10Â ÂµM of MFP-0012328 and 1Â Âµg/mL of LPS for 24Â h. TNF-Î± concentration in LPS-treated BV-2 cells was reduced 24.8% by MFP-0012328 relative to LPS alone-treated BV-2 cells. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰6 biological replicates), where ****pâ€‰&lt;â€‰0.0001, as assessed using a two-way ANOVA, followed by a post-hoc Tukeyâ€™s test. (<strong>B</strong>) mRNA of TNF-Î± in BV-2 cells following treatment with 10Â ÂµM of MFP-0012328 and 1Â Âµg/mL of LPS for 24Â h. TNF-Î± mRNA levels in LPS-treated BV-2 cells were reduced 17% by MFP-0012328 relative to LPS alone-treated BV-2 cells. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰4 biological replicates), where **pâ€‰&lt;â€‰0.01 and ****pâ€‰&lt;â€‰0.0001, as assessed using a two-way ANOVA, followed by a post-hoc Tukeyâ€™s test</p></figcaption></figure></section><section id="Sec21"><h3 class="pmc_sec_title">MFP-0012328 Reduced ROS Production and TNF-Î± Release from BV-2 Cells post LPS Activation</h3>
<p id="Par25">While we have demonstrated that pre-treating BV-2 cells with MFP-0012328 was able to reduce ROS production and TNF-Î± concentration when administered prior to, or in combination with LPS, it was important to confirm that MFP-0012328 still attenuated the release of these proinflammatory molecules following acute LPS activation. Even when BV-2 cells were pre-treated with LPS for 4 h prior to MFP-0012328 exposure, MFP-0012328 was still able to significantly reduce both ROS production and TNF-Î± concentration, by 27.8% and 15.7%, respectively (Fig.Â <a href="#Fig7" class="usa-link">7</a>), albeit the reduction was not as high as when BV-2 cells were treated with the inhibitor before, or in combination with, exposure to LPS.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig.Â 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12000251_11481_2025_10191_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6a/12000251/7db6d90a548c/11481_2025_10191_Fig7_HTML.jpg" loading="lazy" id="MO8" height="549" width="677" alt="Fig.Â 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>A</strong>) ROS production and (<strong>B</strong>) amount of TNF-Î± protein released from BV-2 cells that had been pre-treated with LPS for 4Â h, followed by the addition of 10Â ÂµM of MFP-0012328. ROS levels and TNF-Î± release were reduced by 27.8% and 15.7%, respectively, in the presence of LPS, as compared to LPS-alone treated BV-2 cells. Data are represented as meanâ€‰Â±â€‰SEM (nâ€‰=â€‰6 biological replicates), where *pâ€‰&lt;â€‰0.05 and ****pâ€‰&lt;â€‰0.0001, as assessed using a two-way ANOVA, followed by a post-hoc Tukeyâ€™s test</p></figcaption></figure></section></section><section id="Sec22"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par26">The overactivation of microglia, which leads to the excessive release of proinflammatory molecules, is the main contributor to neuroinflammation. Therefore, efforts to modulate the proinflammatory microglial phenotype can lead to new therapeutic options to reduce neuroinflammation in diseases such as AD, PD and MND. Specific and selective FABP4 inhibitors have been developed which may attenuate microglial-mediated neuroinflammation, given that FABP4 is implicated in this process (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>; Duffy et al. <a href="#CR5" class="usa-link" aria-describedby="CR5">2017</a>), however their physicochemical properties may hinder their development as potential therapeutic entities. This study therefore investigated the potential of novel FABP4 inhibitors, identified using fragment screening and with more drug-like properties, to reduce LPS-mediated inflammation in BV-2 cells since these cells express similar phenotypical, phagocytic, and secretive functions as primary microglia (Henn et al. <a href="#CR11" class="usa-link" aria-describedby="CR11">2009</a>).</p>
<p id="Par27">In order to assess the aqueous solubility of each of the compounds,<sup>1</sup>H-NMR studies were performed in phosphate buffer, which is a widely considered and representative buffer consistent with those used in in vitro pharmacology assays (LaPlante et al. <a href="#CR17" class="usa-link" aria-describedby="CR17">2013a</a>, <a href="#CR18" class="usa-link" aria-describedby="CR18">2013b</a>). It is important for therapeutic compounds to exhibit a high enough aqueous solubility to ensure that the compound can be easily formulated into a dosage form and for subsequent bioavailability following oral administration (Box and Comer <a href="#CR2" class="usa-link" aria-describedby="CR2">2008</a>; Lipinski et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2001</a>; Williams et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2013</a>). <sup>1</sup>H NMR studies showed that all MFP compounds with the sulfonamide scaffold were soluble up to 100Â ÂµM in phosphate buffer. Interestingly, despite the high LogP of BMS309403 (PubChem <a href="#CR28" class="usa-link" aria-describedby="CR28">2021</a>), it also remained in solution at concentrations of up to 100Â ÂµM in phosphate buffer. This unexpectedly high solubility may have been due to the small amount of d<sub>6</sub>-DMSO present in the phosphate buffer, which resulted in the apparent solubility of BMS309403 being largely kinetically driven. Compounds delivered in a DMSO solution to an aqueous medium are usually in a very high energy state, which could enhance apparent solubility (Lipinski et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2001</a>). Therefore, in order to fully quantify the aqueous solubility of the MFP compounds and also BMS309403, equilibrium solubility studies would be required. Since all MFP compounds tested were soluble in aqueous bufferÂ (containing a small amount of d<sub>6</sub>-DMSO) up to a concentration of 100Â ÂµM, this suggests that theyÂ may exhibit suitable solubility for oral administration, albeit this would require confirmation through in vivo oral pharmacokinetic studies.</p>
<p id="Par28">As the MFP compounds in this study have not been tested in any in vitro assays, a cell viability study was first performed to ensure that the concentration chosen for all compounds was well tolerated in BV-2 cells. This is critical to ensure that any changes observed in subsequent pharmacological assays are a specific result of the inhibitor, and not generalised cell death. Given that we were interested in assessing the greatest effect that these compounds would have on proinflammatory molecule release from LPS-activated microglia, the highest tolerable concentration of each of the different inhibitors was initially chosen (i.e. 50Â ÂµM), which is a concentration of BMS309403 that we have previously demonstrated also does not exhibit toxicity to BV-2 cells (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). Although the inhibitor concentrations used in this study were higher than their reported K<sub>D</sub> values, this is common practice for inhibitor studies (Hui et al. <a href="#CR13" class="usa-link" aria-describedby="CR13">2010</a>; Furuhashi et al. <a href="#CR8" class="usa-link" aria-describedby="CR8">2007</a>; Suhre et al. <a href="#CR30" class="usa-link" aria-describedby="CR30">2011</a>). These higher concentrations of inhibitors were employed given the possibility of non-specific adsorption onto cell culture plasticware reducing the free concentration available to exert an effect and the likely differences in cellular access of each inhibitor. By utilising a concentration substantially higher than the K<sub>D</sub>, we can be more confident that the concentration of each inhibitor present at the target site (i.e. cytoplasmic FABP4) would be above the inhibitor K<sub>D</sub>. This concentration of 50Â ÂµM resulted in all inhibitors significantly reducing intracellular ROS production, regardless of their binding affinity towards FABP4, which was unexpected. This phenomenon could be due to an excessive amount of inhibitor saturating all targets within microglia, thus potentially resulting in off-target effects. For this reason, the effect of each of the inhibitors on pro-inflammatory mediator release was assessed at a concentration of 10Â ÂµM. Compounds with a higher K<sub>D</sub> value towards FABP4 (but lower LogP value) were not able to reduce ROS production in LPS-activated microglia as effectively as those with the lower FABP4 K<sub>D</sub> value (TableÂ <a href="#Tab2" class="usa-link">2</a>), suggesting that binding affinity of MFP compound to FABP4 does correlate to ability to inhibit the production of ROS, but not the release of nitrite, from BV-2 cells. While this relationship is expected, it is also theoretically possible that the difference in ability to attenuate inflammatory mediator release is associated with different BV-2 cellular uptake of each inhibitor, and therefore, BV-2 cellular uptake studies could be undertaken to ascertain this possibility. Ultimately, assessment of BBB penetration and microglial uptake following peripheral administration of these FABP4 inhibitors in vivo would support the appropriateness of the concentrations of these compounds used in these in vitro studies. Importantly, the MFP compounds exhibited similar anti-inflammatory effects as we have previously reported for BMS309403 in BV-2 cells. For comparison, a 50Â ÂµM concentration of MFP compounds led to a 23.0â€“54.0% reduction in ROS levels (similar to a 36.0% reduction mediated by the same concentration of BMS309403 (KagawaÂ et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>)) and a 12.2â€“51.3% reduction in nitrite production (similar to a 26.8% reduction mediated by 50Â ÂµM of BMS309403)Â (Duffy et al. <a href="#CR5" class="usa-link" aria-describedby="CR5">2017</a>). Interestingly, MFP-0012328 at a concentration of 10Â ÂµM led to a 24.8% reduction in LPS-mediated TNF-Î± release from BV-2 cells, which was similar to the effect of BMS309403 at a five-fold higher concentration (i.e. 29.0%) (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). This suggests a more potent effect of MFP-0012328 which may be attributed to greater BV-2 cellular access, given that MFP-0012328 has a substantially higher K<sub>D</sub> than BMS309403.</p>
<p id="Par29">Since MFP-0012328 was able to reduce LPS-induced ROS production most significantly, this compound was further investigated in a proinflammatory cellular setting. Further studies demonstrated that MFP-0012328 was also able to reduce the release of ROS and TNF-Î± following acute LPS stimulation (Fig.Â <a href="#Fig7" class="usa-link">7</a>), implying its ability to modulate the proinflammatory microglial phenotype even after the onset of inflammation, which is more clinically relevant. Furthermore, we have also demonstrated that BV-2 cells treated with MFP-0012328 and FABP4 siRNA (which targets the FABP4 mRNA sequence directly) resulted in a similar fold change in ROS production in the presence of FABP4, indicating that the effect of MFP-0012328 on ROS production was FABP4-specific, and not due to any off-target effects, as we have previously demonstrated for BMS309403 (Kagawa et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2023</a>). We have previously demonstrated that treatment of BV-2 cells with FABP4 siRNA results in a 78.0â€“92.3% reduction in FABP4 mRNA and 74.5â€“81.7% reduction in FABP4 protein (Low et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2021</a>), supporting a critical role of FABP4 in the anti-inflammatory effects of MFP-0012328. These studies therefore suggest that MFP-0012328 could be explored as a potential therapeutic tool to reduce FABP4-mediated neuroinflammation in diseases where microglial FABP4 is upregulated.</p>
<p id="Par30">Despite the promising results reported in this study, the accessibility of MFP-0012328 and other MFP compounds to microglial FABP4 in an in vivo setting, following for example, oral administration, remains to be elucidated. Furthermore, whether the more favourable physicochemical properties of these compounds, relative to the more potent BMS309403, leads to improved CNS exposure requires evaluation. Therefore, further studies should be undertaken to assess the ability of these compounds to permeate the BBB using relevant approaches, firstly through in an in vitro setting through the use of primary brain microvascular endothelial cells and furthermore, following in vivo administration to rodents (Nicolazzo et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2006</a>). This could be assisted through the use of radiolabelled analogues of these compounds, as has been possible with the synthesis of <sup>14</sup>C-BMS309403 (Okada et al. <a href="#CR26" class="usa-link" aria-describedby="CR26">2012</a>) or through LCMS/MS quantification of unlabelled compounds (Kooijmans et al. <a href="#CR15" class="usa-link" aria-describedby="CR15">2012</a>). Furthermore, these compounds should also be tested for their efficacy, especially in an in vivo model of inflammation, to ensure that they exhibit similar effects in more complex systems. In addition, due to sex differences potentially impacting on the degree of neuroinflammation (Osborne et al. <a href="#CR27" class="usa-link" aria-describedby="CR27">2018</a>), assessing whether these novel FABP4 inhibitor analogues affect proinflammatory molecule release from microglial in a sex-dependent manner is of interest.</p></section><section id="Sec23"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par31">Overall, this study demonstrated that a series of novel FABP4 inhibitors with physicochemical properties more suitable for BBB penetration effectively reduce the release of proinflammatory molecules from LPS-activated microglia. Despite bothÂ MFP-0012328 and BMS309403 being soluble in phosphate buffer up to 100Â ÂµM, the substantially lower LogP of MFP-0012328 would likely make it an easier drug candidate to scale up and formulate, and hence a more likely candidate to move forward in the drug development process. Therefore, further studies such as drug characterisation, pharmacokinetic/pharmacodynamic studies, and efficacy studies should be performed to support the proposal that MFP-0012328 could indeed be a potential therapeutic compound that may be used to alleviate microglia-induced neuroinflammation in many neurodegenerative diseases.</p></section><section id="Sec24"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12000251/bin/11481_2025_10191_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (DOCX 1040 KB)</a><sup> (1MB, docx) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Authors' Contributions</h2>
<p>All authors contributed to project conceptualisation, experimental design, data interpretation and manuscript preparation. The experiments were conducted by YL, EK and IRC.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>Open Access funding enabled and organized by CAUL and its Member Institutions Yi Ling Low was supported by an Australian Government Research Training Program (RTP) scholarship. Ethan Kreutzer is supported by Monash Universityâ€™s Faculty of Pharmacy and Pharmaceutical Sciences Foundation Board and the Cyril Tonkin Scholarship. Yijun Pan is supported by a National Health and Medical Research Council (NHMRC) Investigator Grant. FightMND is acknowledged for financial support of these studies (IM-202303â€“00885).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data Availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Code Availability</h2>
<p>Not applicable.</p></section><section id="notes5"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing Interests</h3>
<p id="Par32">The authors declare no competing interests.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Ethics Approval</h3>
<p id="Par33">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Consent to Participate</h3>
<p id="Par34">Not applicable.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Consent for Publication</h3>
<p id="Par35">Not applicable.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ol class="ref-list font-sm">
<li id="CR1">
<cite>Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27(2â€“3):229â€“237
</cite> [<a href="https://doi.org/10.1016/0165-5728(90)90073-v" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2110186/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Blasi%20E,%20Barluzzi%20R,%20Bocchini%20V,%20Mazzolla%20R,%20Bistoni%20F%20(1990)%20Immortalization%20of%20murine%20microglial%20cells%20by%20a%20v-raf/v-myc%20carrying%20retrovirus.%20J%20Neuroimmunol%2027(2%E2%80%933):229%E2%80%93237" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<cite>Box KJ, Comer JEA (2008) Using measured pKa, LogP and solubility to investigate supersaturation and predict BCS class. Curr Drug Metab 9(9):869â€“878
</cite> [<a href="https://doi.org/10.2174/138920008786485155" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18991583/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Box%20KJ,%20Comer%20JEA%20(2008)%20Using%20measured%20pKa,%20LogP%20and%20solubility%20to%20investigate%20supersaturation%20and%20predict%20BCS%20class.%20Curr%20Drug%20Metab%209(9):869%E2%80%93878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<cite>de Araujo Boleti AP, de Oliviera Flores TM, Moreno SE, Dos Anjos L, Mortari MR, Migliolo L (2020) Neuroinflammation: an overview of neurodegenerative and metabolic diseases and of biotechnological studies. Neurochem Int 136:104714
</cite> [<a href="https://doi.org/10.1016/j.neuint.2020.104714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32165170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?de%20Araujo%20Boleti%20AP,%20de%20Oliviera%20Flores%20TM,%20Moreno%20SE,%20Dos%20Anjos%20L,%20Mortari%20MR,%20Migliolo%20L%20(2020)%20Neuroinflammation:%20an%20overview%20of%20neurodegenerative%20and%20metabolic%20diseases%20and%20of%20biotechnological%20studies.%20Neurochem%20Int%20136:104714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<cite>Devine SM, Lim SS, Chandrashekaran IR, MacRaild RA, Drew DR, Debono CO, Lam R, Anders FR, Beeson JG, Scanlon MJ, Scammells PJ, Norton RS (2014) A critical evaluation of pyrrolo[2,3-d]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors. MedChemComm 5(10):1500â€“1506</cite> [<a href="https://scholar.google.com/scholar_lookup?Devine%20SM,%20Lim%20SS,%20Chandrashekaran%20IR,%20MacRaild%20RA,%20Drew%20DR,%20Debono%20CO,%20Lam%20R,%20Anders%20FR,%20Beeson%20JG,%20Scanlon%20MJ,%20Scammells%20PJ,%20Norton%20RS%20(2014)%20A%20critical%20evaluation%20of%20pyrrolo%5B2,3-d%5Dpyrimidine-4-amines%20as%20Plasmodium%20falciparum%20apical%20membrane%20antigen%201%20(AMA1)%20inhibitors.%20MedChemComm%205(10):1500%E2%80%931506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<cite>Duffy CM, Xu H, Nixon JP, Bernlohr DA, Butterick TA (2017) Identification of a fatty acid binding protein4-UCP2 axis regulating microglial mediated neuroinflammation. Mol Cell Neurosci 80:52â€“57
</cite> [<a href="https://doi.org/10.1016/j.mcn.2017.02.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5399884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28214555/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Duffy%20CM,%20Xu%20H,%20Nixon%20JP,%20Bernlohr%20DA,%20Butterick%20TA%20(2017)%20Identification%20of%20a%20fatty%20acid%20binding%20protein4-UCP2%20axis%20regulating%20microglial%20mediated%20neuroinflammation.%20Mol%20Cell%20Neurosci%2080:52%E2%80%9357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<cite>Floresta G, Pistara V, Amata E, Dichiara M, Marrazzo A, Prezzavento O, Rescifina A (2017) Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review. Euopean J Med Chem 138:854â€“873</cite> [<a href="https://doi.org/10.1016/j.ejmech.2017.07.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28738306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Floresta%20G,%20Pistara%20V,%20Amata%20E,%20Dichiara%20M,%20Marrazzo%20A,%20Prezzavento%20O,%20Rescifina%20A%20(2017)%20Adipocyte%20fatty%20acid%20binding%20protein%204%20(FABP4)%20inhibitors.%20A%20comprehensive%20systematic%20review.%20Euopean%20J%20Med%20Chem%20138:854%E2%80%93873" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<cite>Furuhashi M, Hotamisligil GS (2008) Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Disc 7(6):489â€“503</cite> [<a href="https://doi.org/10.1038/nrd2589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2821027/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18511927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Furuhashi%20M,%20Hotamisligil%20GS%20(2008)%20Fatty%20acid-binding%20proteins:%20role%20in%20metabolic%20diseases%20and%20potential%20as%20drug%20targets.%20Nat%20Rev%20Drug%20Disc%207(6):489%E2%80%93503" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<cite>Furuhashi M, Tuncman G, GÃ¶rgÃ¼n CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447(7147):959â€“965
</cite> [<a href="https://doi.org/10.1038/nature05844" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4076119/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17554340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Furuhashi%20M,%20Tuncman%20G,%20G%C3%B6rg%C3%BCn%20CZ,%20Makowski%20L,%20Atsumi%20G,%20Vaillancourt%20E,%20Kono%20K,%20Babaev%20VR,%20Fazio%20S,%20Linton%20MF,%20Sulsky%20R,%20Robl%20JA,%20Parker%20RA,%20Hotamisligil%20GS%20(2007)%20Treatment%20of%20diabetes%20and%20atherosclerosis%20by%20inhibiting%20fatty-acid-binding%20protein%20aP2.%20Nature%20447(7147):959%E2%80%93965" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<cite>Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8:359
</cite> [<a href="https://doi.org/10.1038/s41392-023-01588-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10514343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37735487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gao%20C,%20Jiang%20J,%20Tan%20Y,%20Chen%20S%20(2023)%20Microglia%20in%20neurodegenerative%20diseases:%20mechanism%20and%20potential%20therapeutic%20targets.%20Signal%20Transduct%20Target%20Ther%208:359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<cite>Guo D, Lin C, Lu Y, Guan H, Qi W, Zhang H, Shao Y, Zeng C, Zhang R, Zhang H, Bai X, Cai D (2022) FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis. Bone Res 10(1):45
</cite> [<a href="https://doi.org/10.1038/s41413-022-00211-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9213409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35729106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Guo%20D,%20Lin%20C,%20Lu%20Y,%20Guan%20H,%20Qi%20W,%20Zhang%20H,%20Shao%20Y,%20Zeng%20C,%20Zhang%20R,%20Zhang%20H,%20Bai%20X,%20Cai%20D%20(2022)%20FABP4%20secreted%20by%20M1-polarized%20macrophages%20promotes%20synovitis%20and%20angiogenesis%20to%20exacerbate%20rheumatoid%20arthritis.%20Bone%20Res%2010(1):45" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<cite>Henn A, Lund S, HedtjÃ¤rn M, Schrattenholz A, PÃ¶rzgen P, Leist M (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. Altex 26(2):83â€“94
</cite> [<a href="https://doi.org/10.14573/altex.2009.2.83" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19565166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Henn%20A,%20Lund%20S,%20Hedtj%C3%A4rn%20M,%20Schrattenholz%20A,%20P%C3%B6rzgen%20P,%20Leist%20M%20(2009)%20The%20suitability%20of%20BV2%20cells%20as%20alternative%20model%20system%20for%20primary%20microglia%20cultures%20or%20for%20animal%20experiments%20examining%20brain%20inflammation.%20Altex%2026(2):83%E2%80%9394" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<cite>Hertzel AV, Hellberg K, Reynolds JM, Kruse AC, Juhlmann BE, Smith AJ, Sanders MA, Ohlendorf DH, Suttles J, Bernlohr DA (2009) Identification and characterization of a small molecule inhibitor of fatty acid binding proteins. J Med Chem 52(19):6024â€“6031
</cite> [<a href="https://doi.org/10.1021/jm900720m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2755644/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19754198/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hertzel%20AV,%20Hellberg%20K,%20Reynolds%20JM,%20Kruse%20AC,%20Juhlmann%20BE,%20Smith%20AJ,%20Sanders%20MA,%20Ohlendorf%20DH,%20Suttles%20J,%20Bernlohr%20DA%20(2009)%20Identification%20and%20characterization%20of%20a%20small%20molecule%20inhibitor%20of%20fatty%20acid%20binding%20proteins.%20J%20Med%20Chem%2052(19):6024%E2%80%936031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<cite>Hui X, Li H, Zhou Z, Lam KSL, Xiao Y, Wu D, Ding K, Wang Y, Vanhoutte PM, Xu A (2010) Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1. J Biol Chem 285(14):10273â€“10280
</cite> [<a href="https://doi.org/10.1074/jbc.M109.097907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2856232/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20145251/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hui%20X,%20Li%20H,%20Zhou%20Z,%20Lam%20KSL,%20Xiao%20Y,%20Wu%20D,%20Ding%20K,%20Wang%20Y,%20Vanhoutte%20PM,%20Xu%20A%20(2010)%20Adipocyte%20fatty%20acid-binding%20protein%20modulates%20inflammatory%20responses%20in%20macrophages%20through%20a%20positive%20feedback%20loop%20involving%20c-Jun%20NH2-terminal%20kinases%20and%20activator%20protein-1.%20J%20Biol%20Chem%20285(14):10273%E2%80%9310280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<cite>Kagawa Y, Low YL, Pyun J, Doglione U, Short JL, Pan Y, Nicolazzo JA (2023) Fatty acid-binding protein 4 is essential for the inflammatory and metabolic response of microglia to lipopolysaccharide. J Neuroimmune Pharmacol 18(3):448â€“461
</cite> [<a href="https://doi.org/10.1007/s11481-023-10079-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10577108/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37555918/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kagawa%20Y,%20Low%20YL,%20Pyun%20J,%20Doglione%20U,%20Short%20JL,%20Pan%20Y,%20Nicolazzo%20JA%20(2023)%20Fatty%20acid-binding%20protein%204%20is%20essential%20for%20the%20inflammatory%20and%20metabolic%20response%20of%20microglia%20to%20lipopolysaccharide.%20J%20Neuroimmune%20Pharmacol%2018(3):448%E2%80%93461" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<cite>Kooijmans SA, Senyschyn D, Mezhiselvam MM, Morizzi J, Charman SA, Weksler B, Romero IA, Couraud PO, Nicolazzo JA (2012) The involvement of a Na+ and Clâ€“dependent transporter in the brain uptake of amantadine and rimantadine. Mol Pharm 9(4):883â€“893
</cite> [<a href="https://doi.org/10.1021/mp2004127" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22352408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kooijmans%20SA,%20Senyschyn%20D,%20Mezhiselvam%20MM,%20Morizzi%20J,%20Charman%20SA,%20Weksler%20B,%20Romero%20IA,%20Couraud%20PO,%20Nicolazzo%20JA%20(2012)%20The%20involvement%20of%20a%20Na+%20and%20Cl%E2%80%93dependent%20transporter%20in%20the%20brain%20uptake%20of%20amantadine%20and%20rimantadine.%20Mol%20Pharm%209(4):883%E2%80%93893" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<cite>Lan H, Cheng CC, Kowalski TJ, Pang L, Shan L, Chuang C-C, Jackson J, Rojas-Triana A, Bober L, Liu L, Voight J, Orth P, Yang X, Shipps GW Jr, Hedrick JA (2011) Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity. J Lipid Res 52(4):646â€“656
</cite> [<a href="https://doi.org/10.1194/jlr.M012757" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3284158/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21296956/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lan%20H,%20Cheng%20CC,%20Kowalski%20TJ,%20Pang%20L,%20Shan%20L,%20Chuang%20C-C,%20Jackson%20J,%20Rojas-Triana%20A,%20Bober%20L,%20Liu%20L,%20Voight%20J,%20Orth%20P,%20Yang%20X,%20Shipps%20GW%20Jr,%20Hedrick%20JA%20(2011)%20Small-molecule%20inhibitors%20of%20FABP4/5%20ameliorate%20dyslipidemia%20but%20not%20insulin%20resistance%20in%20mice%20with%20diet-induced%20obesity.%20J%20Lipid%20Res%2052(4):646%E2%80%93656" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<cite>LaPlante SR, Aubry N, Bolger G, Bonneau P, Carson R, Coulombe R, Sturino C, Beaulieu PL (2013a) Monitoring drug self-aggregation and potential for promiscuity in off-target in vitro pharmacology screens by a practical NMR strategy. J Med Chem 56(17):7073â€“7083
</cite> [<a href="https://doi.org/10.1021/jm4008714" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23919803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?LaPlante%20SR,%20Aubry%20N,%20Bolger%20G,%20Bonneau%20P,%20Carson%20R,%20Coulombe%20R,%20Sturino%20C,%20Beaulieu%20PL%20(2013a)%20Monitoring%20drug%20self-aggregation%20and%20potential%20for%20promiscuity%20in%20off-target%20in%20vitro%20pharmacology%20screens%20by%20a%20practical%20NMR%20strategy.%20J%20Med%20Chem%2056(17):7073%E2%80%937083" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<cite>LaPlante SR, Carson R, Gillard J, Aubry N, Coulombe R, Bordeleau S, Bonneau P, Little M, Oâ€™Meara J, Beaulieu PL (2013b) Compound aggregation in drug discovery: implementing a practical NMR assay for medicinal chemists. J Med Chem 56(12):5142â€“5150
</cite> [<a href="https://doi.org/10.1021/jm400535b" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23730910/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?LaPlante%20SR,%20Carson%20R,%20Gillard%20J,%20Aubry%20N,%20Coulombe%20R,%20Bordeleau%20S,%20Bonneau%20P,%20Little%20M,%20O%E2%80%99Meara%20J,%20Beaulieu%20PL%20(2013b)%20Compound%20aggregation%20in%20drug%20discovery:%20implementing%20a%20practical%20NMR%20assay%20for%20medicinal%20chemists.%20J%20Med%20Chem%2056(12):5142%E2%80%935150" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<cite>Lee GS, Kappler K, Porter CJ, Scanlon MJ, Nicolazzo JA (2015a) Fatty acid binding proteins expressed at the human blood-brain barrier bind drugs in an isoform-specific manner. Pharm Res 32(10):3432â€“3446
</cite> [<a href="https://doi.org/10.1007/s11095-015-1764-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26248795/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20GS,%20Kappler%20K,%20Porter%20CJ,%20Scanlon%20MJ,%20Nicolazzo%20JA%20(2015a)%20Fatty%20acid%20binding%20proteins%20expressed%20at%20the%20human%20blood-brain%20barrier%20bind%20drugs%20in%20an%20isoform-specific%20manner.%20Pharm%20Res%2032(10):3432%E2%80%933446" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<cite>Lee H-J, Bao J, Miller A, Zhang C, Wu J, Baday YC, Guibao C, Li L, Wu D, Zheng JJ (2015b) Structure-based discovery of novel small molecule Wnt signaling inhibitors by targeting the cysteine-rich domain of frizzled. J Biol Chem 290(51):30596â€“30606
</cite> [<a href="https://doi.org/10.1074/jbc.M115.673202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4683279/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26504084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20H-J,%20Bao%20J,%20Miller%20A,%20Zhang%20C,%20Wu%20J,%20Baday%20YC,%20Guibao%20C,%20Li%20L,%20Wu%20D,%20Zheng%20JJ%20(2015b)%20Structure-based%20discovery%20of%20novel%20small%20molecule%20Wnt%20signaling%20inhibitors%20by%20targeting%20the%20cysteine-rich%20domain%20of%20frizzled.%20J%20Biol%20Chem%20290(51):30596%E2%80%9330606" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<cite>Lin M, Tesconi M, Tischler M (2009) Use of (1)H NMR to facilitate solubility measurement for drug discovery compounds. Int J Pharm 369(1â€“2):47â€“52
</cite> [<a href="https://doi.org/10.1016/j.ijpharm.2008.10.038" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19073245/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lin%20M,%20Tesconi%20M,%20Tischler%20M%20(2009)%20Use%20of%20(1)H%20NMR%20to%20facilitate%20solubility%20measurement%20for%20drug%20discovery%20compounds.%20Int%20J%20Pharm%20369(1%E2%80%932):47%E2%80%9352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<cite>Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1â€“3):3â€“26
</cite> [<a href="https://doi.org/10.1016/s0169-409x(00)00129-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11259830/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lipinski%20CA,%20Lombardo%20F,%20Dominy%20BW,%20Feeney%20PJ%20(2001)%20Experimental%20and%20computational%20approaches%20to%20estimate%20solubility%20and%20permeability%20in%20drug%20discovery%20and%20development%20settings.%20Adv%20Drug%20Deliv%20Rev%2046(1%E2%80%933):3%E2%80%9326" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<cite>Low Y, Jin L, Morris ER, Pan Y, Nicolazzo JA (2020) Pioglitazone increases blood-brain barrier expression of fatty acid-binding protein 5 and docosahexaenoic acid trafficking into the brain. Mol Pharm 17(3):873â€“884
</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.9b01131" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31944767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Low%20Y,%20Jin%20L,%20Morris%20ER,%20Pan%20Y,%20Nicolazzo%20JA%20(2020)%20Pioglitazone%20increases%20blood-brain%20barrier%20expression%20of%20fatty%20acid-binding%20protein%205%20and%20docosahexaenoic%20acid%20trafficking%20into%20the%20brain.%20Mol%20Pharm%2017(3):873%E2%80%93884" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<cite>Low YL, Pan Y, Short JL, Nicolazzo JA (2021) Profiling the expression of fatty acid-binding proteins and fatty acid transporters in mouse microglia and assessing their role in docosahexaenoic acid-d5 uptake. Prostaglandins Leukot Essent Fatty Acids 171:102303
</cite> [<a href="https://doi.org/10.1016/j.plefa.2021.102303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34098488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Low%20YL,%20Pan%20Y,%20Short%20JL,%20Nicolazzo%20JA%20(2021)%20Profiling%20the%20expression%20of%20fatty%20acid-binding%20proteins%20and%20fatty%20acid%20transporters%20in%20mouse%20microglia%20and%20assessing%20their%20role%20in%20docosahexaenoic%20acid-d5%20uptake.%20Prostaglandins%20Leukot%20Essent%20Fatty%20Acids%20171:102303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<cite>Nicolazzo JA, Charman SA, Charman WN (2006) Methods to assess drug permeability across the blood-brain barrier. J Pharm Pharmacol 58(3):281â€“293
</cite> [<a href="https://doi.org/10.1211/jpp.58.3.0001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16536894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nicolazzo%20JA,%20Charman%20SA,%20Charman%20WN%20(2006)%20Methods%20to%20assess%20drug%20permeability%20across%20the%20blood-brain%20barrier.%20J%20Pharm%20Pharmacol%2058(3):281%E2%80%93293" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<cite>Okada T, Hiromura M, Otsuka M, Enomoto S, Miyachi H (2012) Synthesis of BMS-309403-related compounds, including [14C]BMS-309403, a radioligand for adipocyte fatty acid binding protein. Chem Pharm Bull 60(1):164â€“168</cite> [<a href="https://doi.org/10.1248/cpb.60.164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22223390/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Okada%20T,%20Hiromura%20M,%20Otsuka%20M,%20Enomoto%20S,%20Miyachi%20H%20(2012)%20Synthesis%20of%20BMS-309403-related%20compounds,%20including%20%5B14C%5DBMS-309403,%20a%20radioligand%20for%20adipocyte%20fatty%20acid%20binding%20protein.%20Chem%20Pharm%20Bull%2060(1):164%E2%80%93168" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<cite>Osborne BF, Turano A, Schwarz JM (2018) Sex differences in the neuroimmune system. Curr Opin Behav Sci 23:118â€“123
</cite> [<a href="https://doi.org/10.1016/j.cobeha.2018.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6044467/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30014014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Osborne%20BF,%20Turano%20A,%20Schwarz%20JM%20(2018)%20Sex%20differences%20in%20the%20neuroimmune%20system.%20Curr%20Opin%20Behav%20Sci%2023:118%E2%80%93123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28"><cite>PubChem (2021) 2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid. National Center for Biotechnology Information, Bethesda, MD. Available from: <a href="https://pubchem.ncbi.nlm.nih.gov/compound/bms-309403" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubchem.ncbi.nlm.nih.gov/compound/bms-309403</a></cite></li>
<li id="CR29">
<cite>Subhramanyam CZ, Wang C, Hu Q, Dheen ST (2019) Microglia-mediated neuroinflammation in neurodegenerative disesaes. Sem Cell Dev Biol 94:112â€“120</cite> [<a href="https://doi.org/10.1016/j.semcdb.2019.05.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31077796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Subhramanyam%20CZ,%20Wang%20C,%20Hu%20Q,%20Dheen%20ST%20(2019)%20Microglia-mediated%20neuroinflammation%20in%20neurodegenerative%20disesaes.%20Sem%20Cell%20Dev%20Biol%2094:112%E2%80%93120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<cite>Suhre K, RÃ¶misch-Margl W, de Angelis H, Adamski J, Luippold G, Augustin R (2011) Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing. J Biomol Screen 16(5):467â€“475
</cite> [<a href="https://doi.org/10.1177/1087057111402200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21543640/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Suhre%20K,%20R%C3%B6misch-Margl%20W,%20de%20Angelis%20H,%20Adamski%20J,%20Luippold%20G,%20Augustin%20R%20(2011)%20Identification%20of%20a%20potential%20biomarker%20for%20FABP4%20inhibition:%20the%20power%20of%20lipidomics%20in%20preclinical%20drug%20testing.%20J%20Biomol%20Screen%2016(5):467%E2%80%93475" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<cite>Sulsky R, Magnin DR, Huang Y, Simpkins L, Taunk P, Patel M, Zhu Y, Stouch TR, Bassolino-Klimas D, Parker R, Harrity T, Stoffel R, Taylor DS, Lavoie TB, Kish K, Jacobson BL, Sheriff S, Adam LP, Ewing WR, Robl JA (2007) Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg Med Chem Lett 17(12):3511â€“3515
</cite> [<a href="https://doi.org/10.1016/j.bmcl.2006.12.044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17502136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sulsky%20R,%20Magnin%20DR,%20Huang%20Y,%20Simpkins%20L,%20Taunk%20P,%20Patel%20M,%20Zhu%20Y,%20Stouch%20TR,%20Bassolino-Klimas%20D,%20Parker%20R,%20Harrity%20T,%20Stoffel%20R,%20Taylor%20DS,%20Lavoie%20TB,%20Kish%20K,%20Jacobson%20BL,%20Sheriff%20S,%20Adam%20LP,%20Ewing%20WR,%20Robl%20JA%20(2007)%20Potent%20and%20selective%20biphenyl%20azole%20inhibitors%20of%20adipocyte%20fatty%20acid%20binding%20protein%20(aFABP).%20Bioorg%20Med%20Chem%20Lett%2017(12):3511%E2%80%933515" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<cite>Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, Porter CJH (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65(1):315â€“499
</cite> [<a href="https://doi.org/10.1124/pr.112.005660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23383426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Williams%20HD,%20Trevaskis%20NL,%20Charman%20SA,%20Shanker%20RM,%20Charman%20WN,%20Pouton%20CW,%20Porter%20CJH%20(2013)%20Strategies%20to%20address%20low%20drug%20solubility%20in%20discovery%20and%20development.%20Pharmacol%20Rev%2065(1):315%E2%80%93499" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<cite>Zhou X, Zhou S, Tao J, Gao Y, Meng G, Cao D, Gao L (2022) HIV-1 Tat drives the Fabp4/NF-ÎºB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis. J Neurovirol 28(4â€“6):483â€“496
</cite> [<a href="https://doi.org/10.1007/s13365-022-01094-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36070137/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou%20X,%20Zhou%20S,%20Tao%20J,%20Gao%20Y,%20Meng%20G,%20Cao%20D,%20Gao%20L%20(2022)%20HIV-1%20Tat%20drives%20the%20Fabp4/NF-%CE%BAB%20feedback%20loop%20in%20microglia%20to%20mediate%20inflammatory%20response%20and%20neuronal%20apoptosis.%20J%20Neurovirol%2028(4%E2%80%936):483%E2%80%93496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<cite>Zimmerman AW, van Moerkerk HT, Veerkamp JH (2001) Ligand specificity and conformational stability of human fatty acid-binding proteins. Int J Biochem Cell Biol 33(9):865â€“876
</cite> [<a href="https://doi.org/10.1016/s1357-2725(01)00070-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11461829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zimmerman%20AW,%20van%20Moerkerk%20HT,%20Veerkamp%20JH%20(2001)%20Ligand%20specificity%20and%20conformational%20stability%20of%20human%20fatty%20acid-binding%20proteins.%20Int%20J%20Biochem%20Cell%20Biol%2033(9):865%E2%80%93876" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12000251/bin/11481_2025_10191_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary file1 (DOCX 1040 KB)</a><sup> (1MB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p>
<p>Not applicable.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Neuroimmune Pharmacology are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s11481-025-10191-9"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/11481_2025_Article_10191.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.3Â MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12000251/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12000251/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12000251%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12000251/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12000251/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12000251/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40234265/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12000251/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40234265/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12000251/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12000251/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6OzqII2v60QRdywYOEbd32WzJch14Lb622Cbeu43M8EnJDzHJl2dj3pDhgNUFy0y">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
